Sleep duration as a risk factor for cardiovascular disease - A review of the recent literature

Current Cardiology Reviews

Volumn 6, Issue 1, 2010, Pages 54-61

  Nagai, Michiaki ^a,b   Hoshide, Satoshi ^a   Kario, Kazuomi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Shobara City Soryo Clinic   (Japan)

Author keywords

Coronary heart disease; Diabetes mellitus; Hypertension; Sleep duration

Indexed keywords

MELATONIN; PLACEBO;

ADRENERGIC SYSTEM; BRAIN FUNCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIABETES MELLITUS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MORTALITY; NERVOUS SYSTEM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SLEEP; SLEEP DEPRIVATION; SLEEP TIME;

EID: 77951573459     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340310790231635     Document Type: Review

References (71)

1. Uehata T. Long working hours and occupational stress-related cardiovascular attacks among middle-aged workers in Japan. J Hum Ergol 1991; 20: 147-153
2. National Sleep Foundation. National Sleep Foundation Sleep Survey. Washington, DC: National Sleep Foundation; 2001.
3. Bonnet MH, Arand DL. We are chronically sleep deprived. Sleep 1995; 18: 908-911
4. Webb WB, Agnew HW. Are we chronically sleep deprived? Bull Psychon Soc 1975; 6: 47-48
5. National Sleep Foundation: Sleep in America Poll 2003. Washington, DC, National Sleep Foundation, 2003.
6. Pickering TG. Could hypertension be a consequence of the 24/7 Society? The effects of sleep deprivation and shift work. J Clin Hypertens (Greenwich) 2006; 819-822
7. Wolk R, Shamsuzzaman AS, Somers VK. Obesity, sleep apnea, and hypertension. Hypertension 2003; 42: 1067-1074
8. Leung RS, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 2001; 164: 2147-2165
9. Punjabi NM, Polotsky VY. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 2005; 99: 1998-2007. (Pubitemid 41547203)
10. Wingard DL, Berkman LF. Mortality risk associated sleeping patterns among adults. Sleep 1983; 6: 102-107
11. Kripke DF, Simons RN, Garfinkel L, Hammond EC. Short and long sleep and sleeping pills. Arch Gen Psychiatry 1979; 36: 103-116
12. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290: 199-206.
13. National Sleep Foundation. 2002 "Sleep in America" Poll. Washington, DC: National Sleep Foundation; 2002.
14. Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Short sleep duration as a risk factor for hypertension. Analyses of the First National Health and Nutrition Examination Survey. Hypertension 2006; 47: 833-839
15. Lusardi P, Mugellini A, Preti P, Zoppi A, Derosa G, Fogani R. Effects of a restricted sleep regimen on ambulatory blood pressure monitoring in normotensive subjects. Am J Hypertens 1996; 9: 503-505 (Pubitemid 26000076)
16. Lusardi P, Zoppi A, Preti P, Pesce RM, Piazza E, Fogari R. Effects of insufficient sleep on ambulatory blood pressure in hypertensive patients: A 24-h study. Am J Hypertens 1999; 12: 63-68 (Pubitemid 29118231)
17. Tochikubo O, Ikeda A, Miyajima E, Ishii M. Effect of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension 1996; 27: 1318-1324 (Pubitemid 26165637)
18. Zhong X, Hilton HJ, Gates GJ, et al. Increased sympathetic and decreased parasympathetic cardiovascular modulation in normal humans with acute sleep deprivation. J Appl Physiol 2005; 98: 2024-2032. (Pubitemid 40726893)
19. Irwin MR, Valladares EM, Motivala S, Thayer JF, Ehlers CL. Association between nocturnal vagal tone and sleep depth, sleep quality, and fatigue in alcohol dependence. Psychosom Med 2006; 68: 159-166 (Pubitemid 43803231)
20. Irwin MR, Ziegler M. Sleep deprivation potentiates activation of cardiovascular and catecholamine responses in abstinent alcoholics. Hypertension 2005; 45: 252-257 (Pubitemid 40185390)
21. Born J, Lange T, Hansen K, Molle M, Fehm HL. Effects of sleep and circadian rhythm on human circulating immune cells. J Immunol 1997; 158: 4454-4464 (Pubitemid 127483950)
22. Uthgenannt D, Schoolmann D, Pietrowsky R, Fehm HL, Born J. Effects of sleep on the production of cytokines in humans. Psychosom Med1995; 57: 97-104.
23. Irwin M, Mascovich A, Gillin JC, Willoughby R, Pike J, Smith TL. Partial sleep deprivation reduces natural killer cell activity in humans. Psychosom Med 1994; 56: 493-498 (Pubitemid 24373668)
24. Irwin M, McClintick J, Costlow C, Fortner M, White J, Gillin JC. Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J 1996; 10: 643-653 (Pubitemid 26141176)
25. Irwin M, Thompson J, Miller C, Gillin JC, Ziegler M. Effect of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: Clinical implications. J Clin Endocrinol Metab 1999; 84: 1979-1985 (Pubitemid 30647021)
26. Meier-Ewert HK, Ridker PM, Rifai N, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004; 43: 678-683 (Pubitemid 38229544)
27. Folkow B. Mental stress and its importance for cardiovascular disorders; physiological aspects, "from-mice-to-man". Scand Cardiovasc J 2001; 35: 163-172
28. Buell P, Breslow L. Mortality from coronary heart disease in California men who work long hours. J Chorn Dis 1960; 11: 615-626
29. Falger PR, Schouten EGW. Exhaustion, psychological stressors in the work environment, and acute myocardial infarction in adult men. J Psychosom Res 1992; 36: 777-786
30. Netterstrom B, Nielsen FE, Kristensen TS, Bach E, Moller L. Relation between job strain and myocardial infarction: a case control study. Occup Environ Med 1999; 56: 339-342 (Pubitemid 29195187)
31. Theorell T, Rahe RH. Behavior and life satisfactions characteristics of Swedish subjects with myocardial infarction. J Chron Dis 1972; 25: 139-147
32. Sokejima S, Kagamimori S. Working hours as a risk factor for acute myocardial infarction in Japan: case-control study. BMJ 1998; 317: 775-780 (Pubitemid 28427227)
33. Partinen M, Putkonen PT, Kaprio J, Koskenvuo M, Hilakivi I. Sleep disorders in relation coronary heart disease. Acta Med Scand 1982; 660(suppl): 69-83. (Pubitemid 13197979)
34. Liu Y, Tanaka H. The Fukuoka Heart Study Group, Overtime work, insufficient sleep, and risk of non-fatal acute myocardial infarction in Japanese men. Occup Environ Med 2002; 59: 447-451 (Pubitemid 34785692)
35. Ayas NT, White DP, Manson JE, et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 2003; 163: 205-209 (Pubitemid 36120188)
36. Spiegel K, Leproult R, Van Cauter E. Impact of sleep dept on metabolic and endocrine function. Lancet 1999; 354: 1435-1439 (Pubitemid 29494756)
37. Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol 2005; 99: 2008-2019 (Pubitemid 41547204)
38. Gottlieb DJ, Punjabi NM, Newman AB, et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 2005; 165: 863-867
39. Yaggi HK, Araujo AB, McKinlay JB. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 2006; 29: 657-661 (Pubitemid 44115369)
40. Leproult R, Copinschi G, Buxton O, Van Cauter E. Sleep loss results in and elevation of cortisol levels the next evening. Sleep 1997; 20: 865-870 (Pubitemid 27524715)
41. Luboshitzky R, Zabari Z, Shen-Orr Z, Herer P, Lavie P. Disruption of the nocturnal testosterone rhythm by sleep fragmentation in normal men. J Clin Endocrinol Metab 2001; 86: 1134-1139 (Pubitemid 32322993)
42. Barrett-Connor E, Khaw KT. Endogenous sex hormones and cardiovascular disease in men: A prospective population based-study. Circulation 1988; 78: 539-545
43. Haffner SM, Karhapaa P, Mykkanen L, Laakso M. Insulin resistance, body fat distribution, and sex hormones in men. Diabetes 1994; 43: 212-219 (Pubitemid 24033674)
44. Simon D, Preziosi P, Barrett-Connor E, et al. Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study. Diabetologia 1992; 35: 173-177
45. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts Male Aging Study. Diabetes Care 2000; 23: 490-494 (Pubitemid 30185792)
46. Haffner SM, Laakso M, Miettinen H, Mykkanen L, Karhapaa P, Rainwater DL. Low levels of sex hormone-binding globulin and testosterone are smaller, denser low density lipoprotein in normoglycemic men. J Clinic Endocrinol Metab 1996; 81: 3697-3701 (Pubitemid 26339941)
47. Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004; 141: 846-850 (Pubitemid 39601178)
48. Reaven GM, Lithell H, Landsberg L. Hypertenison and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 374-381 (Pubitemid 26049592)
49. Larsen PJ, Enquist LW, Card JP. Characterization of the multisynaptic neuronal control of the rat pineal gland using viral transneuronal tracing. Eur J Neurosci 1998; 10: 128-145 (Pubitemid 28325433)
50. Teclemariam-Mesbah R, Kalsbeek A, Buijs RM, Pevet P. Oxytocin innervation of spinal preganglionic neurons projecting to the superior cervical ganglion in the rat. Cell Tissue Res1997; 287: 481-486
51. Teclemariam-Mesbah R, Ter Horst GJ, Postema F, Wortel J, Bujis RM. Anatomical demonstration of the suprachiasmatic nucleus-pineal pathway. J Comp Neurol 1999; 406: 171-182
52. Kalsbeek A, Drijfhout WJ, Westerink BH, et al. GABA receptors in the region of the dorsomedial hypothalamus of rats are implicated in the control of melatonin and corticosterone release. Neuroendocrinology 1996; 63: 69-78.
53. Kalsbeek A, Garidou ML, Palm IF, et al. Melatonin sees the light: blocking GABA-ergic transmission in the paraventricular nucleus induces daytime secretion of melatonin. Eur J Neurosci 2000; 12: 3146-3154
54. Cui LN, Coderre E, Renaud LP. Glutamate and GABA mediate suprachiasmatic nucleus inputs to spinal-projecting paraventricular neurons. Am J Physiol Regul Integr Comp Physiol 2001; 281: R1283-9.
55. Gerendai I, Toth IE, Boldogkoi Z, Medveczky I, Halasz B. CNS structures presumably involved in vagal control of ovarian function. J Auton Nerv System 2000; 80: 40-45
56. La Fleur SE, Kalsbeek A, Wortel J, Buijs RM. Polysynaptic neural pathways between the hypothalamus, including the suprachiasmatic nucleus, and the liver. Brain Res 2000; 871: 50-56
57. Buijs RM, Chun SJ, Niijima A, Romijn HJ, Nagai K. Parasympathetic and sympathetic control of the pancreas: a role for the suprachiasmatic nucleus and other hypothalamic centers that are involved in the regulation of food intake. J Comp Neurol 2001; 431: 405-423
58. Kreier F, Fliers E, Voshol PJ, et al. Selective parasympathetic innervation of subcutaneous and intra-abdominal fat - functional implications. J Clin Invest 2002; 110: 1243-1250
59. Nagai K, Nagai N, Shimizu K, Chun S, Nakagawa H, Niijima A. SCN output drives the autonomic nervous system: with special reference to the autonomic function related to the regulation of glucose metabolism. Prog Brain Res 1996; 111: 253-272
60. Kalsbeek A, Strubbe JH. Circadian control of insulin secretion and glucose homeostasis is independent of the temporal distribution of feeding. Physiol Behav 1998; 63: 553-558
61. La Fleur SE, Kalsbeek A, Wortel J, Fekkes ML, Buijs RM. A daily rhythm in glucose tolerance: a role for the suprachiasmatic nucleus. Diabetes 2001; 50: 1237-1243
62. Pickering TG. The clinical significance of diurnal blood pressure variations. Dippers and nondippers. Circulation 1990; 81: 700-702
63. Yamamoto M, Yamasaki Y, Kodama M, et al. Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes. Diabetes Care 1999; 22: 2072-2077
64. Goncharuk VD, van Heerikhuize J, Dai JP, Swaab DF, Buijs RM. Neuropeptide changes in the suprachiasmatic nucleus in primary hypertension indicate functional impairment of the biological clock. J Comp Neurol 2001; 431: 320-330
65. Borghi C, Costa FV, Boschi S, Mussi A, Ambrosioni E. Predictors of stable hypertension in young borderline subjects: a five-year follow-up study. J Cardiovas Pharmacol 1986; 8(Suppl 5): S138-41.
66. Eilam R, Malach R, Bergmann F, Segal M. Hypertension induced by hypothalamic transplantation from genetically hypertensive to normotensive rats. J Neurosci 1991; 11: 401-411
67. Dunning BE, Ahren B, Veith RC, Taborsky GJ Jr. Noradrenergic sympathetic neural influence on basal pancreatic hormone secretion. Am J Physiol 1988; 255: E785-92.
68. Scheer FA, Van Montfrans GA, van Someren EJ, Mairuhu G, Buijs RM. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 2004; 43: 192-197
69. Cagnacci A, Cannoletta M, Renzi A, Baldassari F, Arangino S, Volpe A. Prolonged melatonin administration decreases nocturnal blood pressure in women. Am J Hypertens 2005; 18: 1614-1618
70. Grossman E, Laudon M, Yalcin R, et al. Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am J Med 2006; 119: 898-902.
71. Simko F, Paulis L. Melatonin as a potential antihypertensive treatment. J Pineal Res 2007; 42: 319-322